Clinical Trials Directory

Trials / Completed

CompletedNCT00803348

Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty

The Secret Recipe for Femoral Nerve Blockade After Total Knee Arthroplasty: A Randomized, Placebo-controlled, Double-blind Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing total knee arthroscopy (knee replacement) surgery usually receive a femoral nerve block as part of their anesthetic care. Some centers administer the block with a single shot of local anesthetic, which wears off several hours after surgery. Other centers administer the block with a single shot followed by continuous infusion of local anesthetic, typically for 2 to 5 days after surgery. The latter method, though good for pain control, may result in decreased mobility (while the anesthetic is still active), longer hospital stays, and greater risk of falls. This study will see if using a lower concentration of local anesthetic for the continuous femoral nerve block or only the initial single-shot dose will result in increased mobility and shorter hospital stays.

Conditions

Interventions

TypeNameDescription
DRUGBolus of 0.2% ropivicaine 20 mls followed by 0.2% ropivicaine at an infusion rate of 5mls/hr until 0600 on postoperative day 2Initial bolus of 0.2% ropivicaine 20 mls into the femoral catheter followed by 0.2% ropivicaine at an infusion rate of 5mls/hr with patient controlled boluses of 5ml available every 30 mins, until 0600 on the morning of postoperative day 2
DRUGBolus of 0.2% ropivicaine 20 mls followed by 0.1% ropivicaine at an infusion rate of 10mls/hr until 0600 on post-operative day 2Initial bolus of 0.2% ropivicaine 20 mls into the femoral catheter followed by 0.1% ropivicaine at an infusion rate of 10mls/hr with patient controlled boluses of 10mls available every 30 mins, until 0600 on the morning of postoperative day 2
DRUGSaline controlBolus of 0.375% ropivicaine 30 mls followed by saline infusion until 0600 on postoperative day 2

Timeline

Start date
2009-05-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2008-12-05
Last updated
2012-04-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00803348. Inclusion in this directory is not an endorsement.